• 2022-05-30
    The clinical application of HMG-CoA Reductase Inhibitors is to treat:
    A: gastric ulcer
    B: duodenal ulcer
    C: hypertension
    D: hyperlipidemia
    E: angina pectoris
  • D

    内容

    • 0

      There are the complications resulting from peptic ulcers except for( )() A: ulcer bleeding B: constipation C: ulcer perforation D: gastric obstruction

    • 1

      Which of the following is not an invasive factor in peptic ulcer disease() A: H-Pylori B: Gastric acid, pepsin C: Prostaglandin D: Oxygen radical

    • 2

      c) When administration of a proton-pump inhibitor or an H2-receptor blocker produces an immediate increase in gastric pH but ulcer healing that is delayed, because _______.

    • 3

      Which of the following is the most important approach in healing peptic ulcers? A: Neutralizing secreted gastric acid B: Blocking receptor activation of gastric acid secretion C: Inhibiting secretion of gastric acid at the proton pump D: Eradicating infection with H.pylori E: Coating the ulcer crater

    • 4

      Dihydrofolate reductase inhibitors include A: TMP B: MTX C: PAS D: SMZ